CANCER PREVENTION AND CONTROL PROGRAM The UNC Lineberger Cancer Prevention and Control Program focuses on the development, evaluation, and dissemination of evidence-based interventions and policy approaches to improve cancer outcomes in North Carolina and beyond. Our program is comprised of 56 program members and fosters strong collaborations between faculty from the six schools; Schools of Medicine, Public Health, Nursing, Pharmacy, Media and Journalism, and the College of Arts and Sciences and 28 departments. The CPC program has four broad themes: (1) Implementing health promotion interventions to reduce cancer risk factors; (2) Developing cancer communication strategies to improve cancer prevention and control; (3) Improving quality of cancer care and long-term outcomes for cancer survivors; and (4) Studying patterns of cancer care, screening, and prevention to inform interventions and policy initiatives that improve cancer outcomes. Eliminating cancer health disparities is a cross-cutting theme of our program. Highlights of our nationally recognized research by program investigators include: tobacco control policy research on the design and efficacy of graphic cigarette warning labels that is guiding FDA policy; research on sales and marketing of electronic cigarettes, including interventions to prevent adolescent e-cigarette use; research on digital and mobile interventions for diet, obesity, physical activity, and symptom management with particular focus on disadvantaged populations and cancer survivors; novel patient-reported outcomes studies that inform national policy; and implementing interventions in our Catchment area of North Carolina focused on eliminating disparities in access and outcomes. The Program is led by Dr. Kurt M. Ribisl, a behavioral scientist, and Dr. Ethan Basch, a medical oncologist and health services researcher. Program members are PIs of three NCI funded pre- and post-doctoral training grants. The Program adds value in terms of integrative activities and opportunities for intra- and cross-program collaboration; professional development and networking support for junior faculty CPC members; access to shared resources such as the Communications for Health Applications and Interventions, Biostatistics, and Patient-Reported Outcomes Core; as well as space, seminars, retreats, training, and education. Since our last renewal, UNC Lineberger has benefited the Program through strong support for infrastructure, faculty recruitments, extensive use of shared resources, and providing developmental funds as befits one of three major UNC Lineberger strategic directions, ?Optimizing Cancer Outcomes in North Carolina.? During the last funding period, program members have published 1359 cancer-related articles, 26% were intra-programmatic and 19% were inter-programmatic (38% collaborative). In 2019, our program members held grants totaling $18.9M (direct cost) in cancer-relevant extramural funding, including $6.8M (direct costs) from the NCI and $8.9M in other peer-reviewed funding.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089818
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Ren, Jianke; Hathaway, Nathaniel A; Crabtree, Gerald R et al. (2018) Tethering of Lsh at the Oct4 locus promotes gene repression associated with epigenetic changes. Epigenetics 13:173-181
Huang, Weigang; Wang, Xiaoyang; Endo-Streeter, Stuart et al. (2018) A membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes. J Biol Chem 293:1728-1735
Smitherman, Andrew B; Anderson, Chelsea; Lund, Jennifer L et al. (2018) Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort. J Adolesc Young Adult Oncol 7:374-383
Zheng, Xiaojing; O'Connell, Catherine M; Zhong, Wujuan et al. (2018) Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease. J Immunol 200:2941-2956
Jenkins, Mark A; Win, Aung Ko; Templeton, Allyson S et al. (2018) Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol 47:387-388i
Williams, Rebecca S; Derrick, Jason; Liebman, Aliza K et al. (2018) Content analysis of e-cigarette products, promotions, prices and claims on Internet tobacco vendor websites, 2013-2014. Tob Control 27:e34-e40
McRee, Autumn J; Marcom, Paul K; Moore, Dominic T et al. (2018) A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer. Clin Breast Cancer 18:289-297
Efird, William M; Fletcher, Alex G; Draeger, Reid W et al. (2018) Deferoxamine-Soaked Suture Improves Angiogenesis and Repair Potential After Acute Injury of the Chicken Achilles Tendon. Orthop J Sports Med 6:2325967118802792
Patel, Nirali M; Michelini, Vanessa V; Snell, Jeff M et al. (2018) Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing. Oncologist 23:179-185

Showing the most recent 10 out of 1525 publications